Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hirohiko Miyake
Institution:
National Cancer Center Hospital East
Observed institutions:
Kansai Medical University,
National Cancer Centre Japan,
National Cancer Center Hospital East,
Kansai Medical University Medical Center
ORCID:
0009-0004-0379-0180
Observed ORCID:
0009-0004-0379-0180
OpenAlex ID:
A5069710359
Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
·
Clinical Cancer Research
·
6
Simultaneous gastric adenosquamous carcinoma and gastric carcinoma with lymphoid stroma: A case report
2019
·
Hirohiko Miyake
, Chika Miyasaka
, et al.
·
Molecular and Clinical Oncology
·
6
PDF
Digitally quantified area of residual tumor after neoadjuvant chemotherapy in HER2-positive breast cancer
2025
·
Mao Uematsu
, Hiromichi Nakajima
, et al.
·
Breast Cancer
·
2
PDF
Supplementary Figure S5 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Supplementary Figure S1 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Data from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Supplementary Figure S4 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Supplementary Table S1 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Supplementary Figure S2 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Supplementary Figure S3 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Supplementary Table S2 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
A case of diffusely infiltrating colorectal cancer with distinctive endoscopic and histologic findings
2023
·
Takashi Obana
, Katsuji Tokuhara
, et al.
·
iGIE
Show more works
View as search
Works count:
12
Citation count:
14
H-index:
2
I10-index:
Year
Topic
Type